Daan Gene's (SHE:002030) unit, Guangzhou Darui Biotechnology, obtained a medical device registration certificate from the Chinese drug administration for an assay kit detecting syphilis treponema, according to a Shenzhen Stock Exchange filing on Thursday.
The certificate, valid until Feb. 10, 2030, is for the syphilis treponema antibody detection kit (chemiluminescent immunoassay), the Chinese medical laboratory company said.
The company's shares soared 10% in recent trade.